Double patch closure of ventricular septal defect with increased pulmonary vascular resistance

W M Novick1, A T Gurbuz, D C Watson

  • 1Le Bonheur Children's Medical Center, University of Tennessee, Memphis, USA. ichfno@aol.com

Insights

A novel flap valve double VSD patch effectively reduces complications in children undergoing large ventricular septal defect (VSD) repair. This technique lowers postoperative morbidity and mortality in pediatric patients with elevated pulmonary vascular resistance.

Area of Science:

  • Pediatric Cardiac Surgery
  • Congenital Heart Disease
  • Cardiovascular Surgery

Background:

  • Large ventricular septal defects (VSD) in children with elevated pulmonary vascular resistance carry high risks of morbidity and mortality.
  • Pulmonary hypertensive episodes are a significant postoperative concern.
  • A new surgical approach was developed to mitigate these risks.

Purpose of the Study:

  • To evaluate the safety and efficacy of a fenestrated flap valve double VSD patch.
  • To reduce morbidity and mortality in pediatric VSD closure with elevated pulmonary vascular resistance.

Main Methods:

  • Eighteen children with large VSDs and elevated pulmonary vascular resistance underwent repair using a fenestrated flap valve double VSD patch.
  • The procedure involved moderately hypothermic cardiopulmonary bypass and cardioplegic arrest.
  • A unique double patch technique with a fenestrated primary patch was employed.

Main Results:

  • All patients survived the surgery and were weaned from support within 48 hours.
  • Postoperative pulmonary artery pressures were significantly reduced compared to preoperative levels.
  • One late mortality occurred 9 months postoperatively.

Conclusions:

  • The flap valve double VSD patch is a safe and effective method for closing large VSDs in children with elevated pulmonary vascular resistance.
  • This technique significantly lowers postoperative morbidity and mortality.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Pulmonary Edema II: Pathophysiology01:18

Pulmonary Edema II: Pathophysiology

Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...